City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Narendra Modi
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Marathi
|
Hindi
x
Epaper
FOLLOW US :
Home
City
City
Ahmednagar
Akola
Amravati
Aurangabad
Beed
Bhandara
Buldhana
Chandrapur
Dhule
Gadchiroli
Goa
Gondia
Hingoli
Jalana
Jalgaon
Kolhapur
Latur
Malegaon
Nagpur
Nanded
Nandurbar
Nashik
Navi Mumbai
Pandharpur
Parabhani
Pimpri-Chinchwad
Pune
Raigad
Ratnagiri
Sangli
Satara
Sindhudurga
Solapur
Thane
Usmanabad
Vardha
Vasai Virar
Vashim
Yavatmal
Khamgaon
Bhusawal
Palghar
Itanagar
Dispur
Patna
Raipur
Panaji
Gandhinagar
Shimla
Ranchi
Bengaluru
Thiruvananthapuram
Bhopal
Mumbai
Imphal
Shillong
Aizawl
Kohima
Bhubaneswar
Jaipur
Gangtok
Chennai
Hyderabad
Agartala
Lucknow
Dehradun
Gairsain
Kolkata
Port Blair
Chandigarh
Daman
New Delhi
Srinagar
Jammu
Kavaratti
Pondicherry
Leh
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
All
News
Photos
The Annotated C++ Reference Manual
FOLLOW
Subject-expert-committee, Latest Marathi News
National :
NTAGI recommends vaccination for Typhoid and Cervical cancer: Sources
Health :
Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC
Health :
DCGI grants EUA to 3 Covid vaccines for different age group of children
National :
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds
National :
Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age group: Official sources
National :
Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19
National :
Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19
National :
DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources
National :
Biological E gets approval to conduct trials of Corbevax as booster dose
National :
Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources
Next Page